TipRanks
CanSino Biologics, Inc. Class H (DE:CJH)
FRANKFURT:CJH

CanSino Biologics, Inc. Class H (CJH) Revenue

2 Followers

CanSino Biologics, Inc. Class H Revenue

CanSino Biologics, Inc. Class H had a revenue of 358.01M in the quarter ending Jun 30, 2026, with 89.86%. This bring the company's revenue in the last twelve months to 1.23B, Decreased 10.13%. In the fiscal year ending Dec 31, 2025, CanSino Biologics, Inc. Class H had annual revenue of 1.03B with 21.93% growth.
Revenue (ttm)
1.23B
Revenue Growth
29.17%
P/S Ratio
1.36
Revenue/Employee
€910,031
Employees
1,134
Market Cap
€1.40B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
1.03B185.64M+21.93%
Dec 31, 2024
846.34M501.16M+145.19%
Dec 31, 2023
345.18M-685.86M-66.52%
Dec 31, 2022
1.03B-3.27B-76.02%
Dec 31, 2021
4.30B4.27B+17,174.82%
Dec 31, 2020
24.89M22.61M+990.05%
Dec 31, 2019
2.28M1.15M+101.71%
Dec 31, 2018
1.13M-8.05M-87.67%
Dec 31, 2017
9.18M